BE900660A - Composition therapeutique pour le traitement des sequelles d'intoxication. - Google Patents

Composition therapeutique pour le traitement des sequelles d'intoxication.

Info

Publication number
BE900660A
BE900660A BE0/213709A BE213709A BE900660A BE 900660 A BE900660 A BE 900660A BE 0/213709 A BE0/213709 A BE 0/213709A BE 213709 A BE213709 A BE 213709A BE 900660 A BE900660 A BE 900660A
Authority
BE
Belgium
Prior art keywords
treatment
sequelles
poisoning
therapeutic composition
intoxication
Prior art date
Application number
BE0/213709A
Other languages
English (en)
Inventor
P Guinot
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of BE900660A publication Critical patent/BE900660A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compositions thérapeutiques contenant des sels de bétaine, pour le traitement de séquelles d'intoxication et abaisser le taux d'alcool dans le sang. La dose journalière consiste en une administration par voie orale de 1 à 30 g, en association avec un support approprié. Des ingrédients facultatifs sont : analgésique, agent de tamponnement et caféine.
BE0/213709A 1983-09-24 1984-09-24 Composition therapeutique pour le traitement des sequelles d'intoxication. BE900660A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838325627A GB8325627D0 (en) 1983-09-24 1983-09-24 Therapeutic compositions

Publications (1)

Publication Number Publication Date
BE900660A true BE900660A (fr) 1985-03-25

Family

ID=10549272

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/213709A BE900660A (fr) 1983-09-24 1984-09-24 Composition therapeutique pour le traitement des sequelles d'intoxication.

Country Status (5)

Country Link
US (2) US4593020A (fr)
JP (1) JPS6092215A (fr)
BE (1) BE900660A (fr)
DE (1) DE3435040A1 (fr)
GB (1) GB8325627D0 (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3440288C2 (de) * 1984-11-05 1987-03-12 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen sowie Verfahren zu ihrer Herstellung
US5202354A (en) * 1986-02-18 1993-04-13 Takeda Chemical Industries, Ltd. Composition and method for reducing acetaldehyde toxicity
FI82483C (fi) * 1986-12-03 1991-03-11 Inst Biolog Morya Dalnevostoch Foerfarande foer framstaellning av en alkoholdryck.
US4808574A (en) * 1986-12-03 1989-02-28 Nauchno-Issledovatelsky Institut Sadovodstva Composition inhibiting pathological addiction to alcohol
US5296241A (en) * 1991-04-03 1994-03-22 Brimberg Barnett J Therapeutic composition and method of using same for treatment of hangover
USD352176S (en) 1992-09-21 1994-11-08 PKK, Incorporated Sports memorabilia holder
KR970008105B1 (ko) * 1993-06-28 1997-05-21 주식회사 미원 L-아스파테이트 또는 아스파라긴을 유효성분으로 함유하는 알콜성 장해 보호제 및 그의 제조방법
JP3119430B2 (ja) * 1995-07-25 2000-12-18 大鵬薬品工業株式会社 水酸基ラジカル消去剤
US20040229203A1 (en) * 1996-06-14 2004-11-18 Biostore New Zealand Ltd. Compositions and methods for the preservation of living tissues
US6361933B1 (en) * 1996-06-14 2002-03-26 Biostore New Zealand Limited Solutions for the preservation of tissues
US6743575B2 (en) 1996-06-14 2004-06-01 Biostore New Zealand Ltd. Compositions and methods for the preservation of living tissues
WO2000012071A2 (fr) * 1998-08-29 2000-03-09 Miklos Ghyczy Produit pharmaceutique et/ou dietetique
DE19839443A1 (de) * 1998-08-29 2000-03-02 Miklos Ghyczy Arnzneimittel mit entzündungshemmender Wirkung
US7608640B2 (en) * 1999-03-02 2009-10-27 Jallal Messadek Glycine betaine and its use
US6440983B1 (en) * 2000-12-21 2002-08-27 Mary Theresa Frank-Kollman Compositions and methods for relieving headache symptoms in aspirin-sensitive headache sufferers
BE1015608A6 (fr) * 2003-07-15 2005-06-07 Messadek Jallal Traitement des arterites.
AU2002343174A1 (en) * 2002-11-25 2004-06-18 Rachid Ennamany Betaine and salicylic acid compositions
US7160565B2 (en) * 2003-03-31 2007-01-09 Breakthru Products, Llc Hydration beverage and method of delivering nutrients
ATE347358T1 (de) * 2003-04-17 2006-12-15 Jallal Messadek Schwimmende orale formulierungen mit kontrollierter freisetzung von betain
US20050276839A1 (en) * 2004-06-10 2005-12-15 Rifkin Calman H Appetite satiation and hydration beverage
BE1016128A6 (fr) * 2004-07-22 2006-03-07 Messadek Jallal Combinaisons therapeutiques
WO2006050581A2 (fr) * 2004-11-10 2006-05-18 Jallal Messadek Betaine en tant qu'agent de lutte contre des maladies transmises par des arthropodes ou des moustiques
EP2242489A1 (fr) * 2005-02-15 2010-10-27 Jallal Messadek Compositions therapeutiques combinees et leurs procedes d utilisation
CN101180073A (zh) 2005-04-27 2008-05-14 贾拉尔·梅萨德克 胰岛素组合
US7879374B2 (en) * 2005-07-22 2011-02-01 Cellutions, LLC Composition including superoxide dismutase and prickly-pear cactus for minimizing and preventing hangovers
KR100779419B1 (ko) 2005-07-26 2007-11-30 대한민국 중독성이 경감된 진통제
WO2009065193A1 (fr) * 2007-11-21 2009-05-28 Jallal Messadek Traitement de la résistance à l'aspirine par de la bétaïne et/ou de la mélasse enrichie en bétaïne
US8377907B1 (en) 2011-02-21 2013-02-19 William A. Halamicek, III Compositions for treating alcohol hangover
ES2388515B1 (es) * 2011-03-18 2013-10-01 Dr Healthcare España, S. L. Uso de la diaminooxidasa para la prevención de los síntomas de la resaca.
US12201676B2 (en) 2011-03-18 2025-01-21 Dr Healthcare España, S.L. Composition comprising diamine oxidase for use in the treatment or prevention of fibromyalgia or chronic fatigue syndrome
ES2426539B1 (es) 2012-04-18 2014-09-09 Dr Healthcare España, S. L. Uso de la diaminooxidasa para el tratamiento o la prevención del trastorno por deficit de atencion con hiperactividad (adhd)
AU2014369916A1 (en) 2013-12-24 2016-06-16 Durect Corporation Uses of oxygenated cholesterol sulfates (OCS)
US20210353575A1 (en) * 2018-10-16 2021-11-18 Nippon Chemiphar Co., Ltd. Agent for suppressing alcohol sickness or hangover due to alcoholic beverage ingestion
CN113825408A (zh) * 2019-05-03 2021-12-21 赢创运营有限公司 含有甜菜碱盐的饲料组合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4049803A (en) * 1976-04-26 1977-09-20 Bristol-Myers Company Augmentation of blood levels of aspirin

Also Published As

Publication number Publication date
GB8325627D0 (en) 1983-10-26
US4703045A (en) 1987-10-27
US4593020A (en) 1986-06-03
JPS6092215A (ja) 1985-05-23
JPH0432802B2 (fr) 1992-06-01
DE3435040A1 (de) 1985-04-04

Similar Documents

Publication Publication Date Title
UA42061C2 (uk) Фармацевтична композиція для перорального введення, що містить інгібітори протонного насоса
KR920002144A (ko) 아연 l-카르노신 염 또는 이의 착화합물을 유효성분으로 함유하는 염증성 장질환 예방 및 치료제
MX163955B (es) Composicion farmaceutica de dihidrocodeina e ibuprofen
FR2435471A1 (fr) Derives de dihydropyridine, procedes d'obtention et compositions pharmaceutiques en contenant
UA32636C2 (uk) Засіб для зниження вмісту холестерину в сироватці крові людини
DE69532031D1 (de) Schilddrüsenhormone enthaltende mittel
MA27153A1 (fr) Formulations pharmaceutiques de derives de platine
SE8903914D0 (sv) Oral composition for the treatment of inflammatory bowel diseases
MA27443A1 (fr) Oxazoles et thiazoles nouveaux servant d'inhibiteurs du facteur de croissance transformant (tgf)
ATE62414T1 (de) Mittel zur behandlung von herzerkrankungen.
BR9906920A (pt) "tts contendo um antioxidante"
TR200103153T2 (tr) Yeni bileşimler
PT969843E (pt) Composicoes antitussicas contendo teobromina
ATE82681T1 (de) 2',3'-dideoxy-3'-fluorothymidin und verwandte verbindungen zur behandlung von adenovirusinfektionen.
FR2358162A1 (fr) Compositions pharmaceutiques basiques renfermant un preservateur
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
TNSN90021A1 (fr) Procede de preparation de tetrahydroimidazo (1,4) benzodiazepin -2- thiones antivirales
FR2438654A1 (fr) Compose de 2-methyl-dihydropyridine, procedes pour son obtention et composition pharmaceutique contenant ce compose
HUP9801924A2 (hu) Nátrium/hidrogén-csere inhibitorokat és szív- és keringési zavarok kezelésére alkalmas hatóanyagokat tartalmazó gyógyszerkészítmény
FR2685918B1 (fr) Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant.
GB2331926A (en) Pharmaceutical compositions containing ibuprofen and domperidone for the treatment of migraine
FR2500303B1 (fr)
FR2358893A1 (fr) Composition antimicrobienne contenant des 1-imidazolyl-butane-2-ones ou -butane-2-ols halogenes
ATE44467T1 (de) Fibrinolytisches mittel und diffusionsfaktor enthaltende pharmazeutische zusammensetzung verwendbar zur behandlung des myokardinfarktes.
BR9809159A (pt) Composição farmacêutica contendo uscaridina ou seus análogos

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SOC.DE CONSEILS DE RECHERCHES ET D APPLICATIONS S

Effective date: 19980930